Regeneron Pharmaceuticals
REGN
REGN
968 hedge funds and large institutions have $49.5B invested in Regeneron Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 147 funds opening new positions, 367 increasing their positions, 304 reducing their positions, and 88 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
5% more funds holding
Funds holding: 921 → 968 (+47)
0.19% less ownership
Funds ownership: 85.2% → 85.01% (-0.19%)
17% less call options, than puts
Call options by funds: $1.04B | Put options by funds: $1.25B
Holders
968
Holding in Top 10
18
Calls
$1.04B
Puts
$1.25B
Top Buyers
| 1 | +$381M | |
| 2 | +$208M | |
| 3 | +$143M | |
| 4 |
HM
HealthCor Management
New York
|
+$96.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$95.6M |
Top Sellers
| 1 | -$606M | |
| 2 | -$444M | |
| 3 | -$312M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$256M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$183M |